Humana Inc. (NYSE:HUM) Shares Bought by Russell Investments Group Ltd.
Russell Investments Group Ltd. boosted its stake in Humana Inc. (NYSE:HUM) by 103.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 531,105 shares of the insurance provider’s stock after buying an additional 269,940 shares during the period. Russell Investments Group Ltd. owned about 0.37% of Humana worth $127,800,000 at the end of the most recent quarter.
Other large investors have also recently made changes to their positions in the company. Independent Portfolio Consultants Inc. raised its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares during the period. Guardian Life Insurance Co. of America raised its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Humana during the first quarter valued at approximately $128,000. Westbourne Investment Advisors Inc. purchased a new stake in shares of Humana during the second quarter valued at approximately $205,000. Finally, Hengehold Capital Management LLC purchased a new stake in shares of Humana during the second quarter valued at approximately $209,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.
Humana Inc. (NYSE:HUM) opened at 233.50 on Thursday. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $243.74. The stock has a market capitalization of $33.70 billion, a PE ratio of 23.80 and a beta of 0.91. The firm has a 50-day moving average of $236.02 and a 200-day moving average of $219.72.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The business had revenue of $13.76 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same period last year, the business posted $1.86 EPS. On average, equities analysts expect that Humana Inc. will post $11.15 EPS for the current year.
HUM has been the subject of several research reports. UBS AG restated a “neutral” rating and set a $237.00 price objective (up from $205.00) on shares of Humana in a research report on Wednesday, June 28th. Zacks Investment Research downgraded Humana from a “hold” rating to a “sell” rating in a research report on Thursday. Cowen and Company restated a “buy” rating and set a $230.00 price objective on shares of Humana in a research report on Friday, July 14th. Piper Jaffray Companies restated a “buy” rating and set a $246.00 price objective on shares of Humana in a research report on Friday, July 14th. Finally, BidaskClub downgraded Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $236.00.
In other Humana news, CEO Bruce D. Broussard sold 118,231 shares of the firm’s stock in a transaction on Thursday, May 4th. The shares were sold at an average price of $225.82, for a total value of $26,698,924.42. Following the sale, the chief executive officer now directly owns 171,170 shares in the company, valued at approximately $38,653,609.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Timothy S. Huval sold 13,939 shares of the firm’s stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $225.86, for a total transaction of $3,148,262.54. Following the completion of the sale, the vice president now owns 23,639 shares in the company, valued at $5,339,104.54. The disclosure for this sale can be found here. Insiders sold a total of 143,241 shares of company stock worth $32,446,903 over the last 90 days. Company insiders own 0.80% of the company’s stock.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.